Paul Hudson, Sanofi CEO (Eric Piermont/AFP via Getty Images)

Ap­peals court quash­es Sanofi’s big win on bell­wether hair loss case

Sanofi thought it had emerged vic­to­ri­ous from the first case of thou­sands to go to tri­al over its chemother­a­py drug Tax­otere — but on Thurs­day, a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.